The Quantellect read.As of Nov 19, 2026, 10 active firms cover HealthEquity Inc: 9 rate it Buy or better, 0 sit at Neutral, and 1 rate it Sell or worse, a buy consensus. Targets span $89.00 to $142.00, a moderate spread. The average target of $114.30 sits 18% above the current $97.27. The rating mix has stayed broadly stable, with Buy-side ratings easing from 10 to 9 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.10 next quarter toward $5.52 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS10 active firms
Buy
Strong Buy00%
Buy990%
Neutral00%
Sell110%
Strong Sell00%
Based on 10 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$114.30
+17.5% upside
Average target across 10 active firms as of Nov 19, 2026 vs $97.27 current
Highest Target$142.00
Average Target$114.30
Lowest Target$89.00
Detailed analyst forecasts for HQY
Showing 1–12 of 12 named analysts shown · 10 active firms in the rating projection
As of Nov 19, 2026, 9 of 10 active firms rate HQY a Buy (0 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
HQY EPS & revenue forecast
EPS · NEXT QUARTER
$1.10
Range $1.05 – $1.16 · 14 analysts · +16% YoY
Next period, 14 analysts expect HealthEquity Inc to earn $1.10 a share (range $1.05 – $1.16), versus $0.95 a year earlier. Full-year consensus is $4.72, growing to $5.52 the year after.
REVENUE · NEXT QUARTER
$364.0M
Range $359.5M – $366.8M · 14 analysts · +9% YoY
Revenue is expected to reach $364.0M (range $359.5M – $366.8M), +8.8% year-over-year. Full-year consensus is $1.4B, rising to $1.5B next year.
Top analysts covering HealthEquity Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on HQY.
#1
Alexander Paris
Barrington Research · Rank #163
Buy
$110.00+13.1% to target
Overall win rate
51%
+ Follow
#2
C. Gregory Peters
Raymond James · Rank #240
Buy
$100.00+2.8% to target
Overall win rate
52%
+ Follow
#3
Brian Tanquilut
Jefferies · Rank #280
Buy
$108.00+11.0% to target
Overall win rate
46%
+ Follow
#4
Constantine Davides
JMP Securities · Rank #454
Buy
$111.00+14.1% to target
Overall win rate
32%
+ Follow
#5
Scott Schoenhaus
Keybanc · Rank #540
Buy
$125.00+28.5% to target
Overall win rate
30%
+ Follow
HQY stock forecast FAQ
What is HQY's average 12-month price target?+
The 10 active firms with a live target average $114.30 for HealthEquity Inc over the next 12 months, ranging from a $142.00 high to a $89.00 low, as of Nov 19, 2026.
Is HQY stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 10 active firms as of Nov 19, 2026, 9 rate it Buy or Strong Buy, 0 rate it Neutral, and 1 rate it Sell or Strong Sell.
What are the highest and lowest price targets for HQY?+
The Street-high target is $142.00 (Deutsche Bank), and the Street-low is $89.00 (Goldman Sachs). The average of all 10 active-firm targets is $114.30.
How many active Wall Street firms cover HQY?+
10 active firms have a recognized rating on HealthEquity Inc as of Nov 19, 2026, and 10 active firms carry a live 12-month price target.
Who is the most accurate analyst covering HQY?+
Among analysts who currently cover HQY, Alexander Paris of Barrington Research has the strongest overall Quantellect track record (Rank #163). Their current call is Buy with a $110.00 target.
What is HealthEquity Inc's projected EPS for next quarter?+
The consensus estimate is $1.10 per share (range $1.05 – $1.16) across 14 analysts. Full-year EPS is projected at $4.72, rising to $5.52 the following year.
How much revenue is HealthEquity Inc expected to report next quarter?+
Consensus revenue is $364.0M (range $359.5M – $366.8M). Full-year revenue is projected at $1.4B, growing to $1.5B next year.
Have analysts been upgrading or downgrading HQY lately?+
As of Nov 19, 2026, 9 of 10 active firms rate HQY a Buy (0 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their HQY calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.